ASCO GU: BP Reveals Hit or Miss for Targeted Tx
SAN FRANCISCO -- Early response to preoperative targeted therapy for metastatic renal cell carcinoma may indicate efficacy, while treatment-induced hypertension may be another marker after surgery, according to studies reported here.
Mar 09, 2010